$22.95
+1.10(5.06%)
52W $7.04 – $26.10
AI-generated
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States.
Revenue breakdown: License And Development Services (82.4%), Other Collaboration Revenue (10.8%), Access Rights (4.2%).
$2.3BMkt Cap
$232MRev TTM
-$331MNI TTM
-6.5xP/E TTM
What Changed Recently
Fundamentals
How The Business Makes Money
Revenue by Segment
License And Development Services82.4%($1.5B)
Other Collaboration Revenue10.8%($198M)
Access Rights4.2%($77M)
RD Services1.2%($22M)
License Revenue1.2%($22M)
Other Services0.3%($5M)
Analyst View
Company Profile
CIK0001724521
ISINUS03969F1093
CUSIP03969F109
Phone510 694 6200
Address3928 Point Eden Way, Hayward, CA, 94545, US
SEC EDGAR